Acupuncture for Lung Cancer-Related Fatigue
ConditionLung Cancer
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-75
SponsorGuang'anmen Hospital of China Academy of Chinese Medical Sciences
About this trial
This study aims to evaluate the efficacy and safety of acupuncture in alleviating cancer-related fatigue (CRF) among lung cancer survivors. It addresses the key issue of limited high-quality evidence for acupuncture's effect on CRF by rigorously comparing real acupuncture against a non-penetrating sham needle control in 120 eligible participants. Patients will be centrally randomized (1:1), blinded, and receive 12-session treatment over 4 weeks. Participants will complete treatment and attend follow-up visits up to week 16, and repeatedly complete fatigue (BFI-C, MFI-20), psychological (PHQ-9, GAD-7, FCRI), functional (CWSAS), and sleep (ISI) assessments.
Eligibility criteria
Qualifiers
Patients with a history of lung cancer who have completed initial treatment (including surgery, radiotherapy, and/or chemotherapy) at least 8 weeks prior;
Aged between 18 and 75 years;
Meet the diagnostic criteria for cancer-related fatigue;
Estimated to have a survival period of at least 3 months;
Disqualifiers
Patients experiencing significant fatigue symptoms before being diagnosed with lung cancer;
Patients with severe anxiety and depression;
Patients showing notable cognitive impairment or suicidal tendencies;
Patients with a history of hypothyroidism or chronic fatigue syndrome;
Trial design
Treatments tested in this trial
- Acupuncture
- Sham Comparator
Treatment groups
120 Participants
are divided into 2 treatment groupsLocations
Sponsors and collaborators
Source ClinicalTrials.gov